In-Vitro Diagnostics Market Global Briefing 2018
Including: Molecular Diagnostics, Point-of-Care Diagnostics, Immunochemistry, Microbiology, Hematology and Immunohematology
Covering: Siemens Healthineers, F. Hoffmann-La Roche Ltd, Danaher (Beckman Coulter Inc), Abbott Laboratories Inc., Thermo Fisher Scientific, Inc., Sysmex Corporation
The Business Research Company’s reports are based on the methodology below.
Our datasets are created using a wide range of proprietary and public sources including leading government bodies, associations, trade journals, market intelligence reports and trade magazines. Data is modelled based on hard data, extrapolation, regression analysis based on known macro data inputs, interpolation between hard figures, comparisons with other geographies and markets, price estimations, and qualitative inputs. Data is triangulated within our unique market data model covering an exhaustive list of 200+ markets across 12 countries and 5 regions. Comparable data is used for sanity check and trend analysis. For example, our global market value data is compared to unit sales and price data for the relevant market as well as relevant macro-economic datasets in order to establish validity.
Market value is defined as the revenues earned by organizations for products and services within the specified market. The break down by geography is revenue generated within the specific industry by organizations in the specified geography, irrespective of where they are produced.
Competitor Market Share Data
The competitor market share data is intended to represent the companies that gain the most revenues from the given market and the percentage share of the market that they hold. If a company derives most of its revenues from the market, its revenues are given in full. If a large part of the company's revenues come from other markets, only the division of the company which operates in this market is included. Where accurate information is not available on the revenues a company generates from the market its market share is not included, however a profile of the company may still be included if it is a significant competitor in the market.
Analysis is drawn from our consultants’ wide range of industry and research experience as well as public and proprietary sources. Consultants are trained in research techniques and ethics by the Market Research Society
Verification Through Expert Interviews
Every year The Business Research Company carries out thousands of interviews with senior executives and industry experts across hundreds of markets. Through these interviews we develop our internal understanding of markets and geographies and cross reference our understanding of global markets with expert feedback utilizing ‘Delphic’ research methodologies.
The Business Research Company prides itself on the quality and validity of its data and analysis. Our unique ‘end noted’ referencing approach allows the user to trace our market numbers and analysis back to the specific data sources they were derived from.
Note on Currency Conversions
All currency conversions are done on the basis of 2015 exchange rates
In-vitro diagnostics (IVD) are used to detect diseases, infections, and conditions and also monitor a person’s state of health and therapeutic procedures by examining specimens derived from the human body such as tissue, blood, stools, urine and the other body fluids. Significant technologies incorporated in in-vitro diagnostics are polymerase chain reaction, microarray techniques, sequencing technology and mass spectrometry, which are used for test sample preparation. In-vitro diagnostic medical devices include reagents, reagent products, control materials, calibration materials, kits, instruments, apparatus, systems, equipment, pregnancy tests, urine test strips, blood sugar monitoring systems for diabetics and receptacles for medical specimens.
Asia Pacific was the largest region in the in-vitro diagnostics market in 2017, accounting for around 32% market share. North America was the second largest region accounting for around 26% market share. Africa was the smallest region accounting for around 4% market share.
Companies in this market are very active with multiple strategic collaborations and agreements. Top companies in the in-vitro diagnostic market are strategically partnering and collaborating with other companies to broaden their products, technologies and services. For instance, In February 2015, Roche acquired Signature Diagnostics to strengthen its cancer diagnostics effort with Signature’s expertise in both next-generation sequencing (NGS) assays and biobanks. In February 2014, Thermo Fisher Scientific acquired the Life Technologies Corporation to transform into a major player in the segment of next-generation sequencing space
- Table 1 : Global In-Vitro Diagnostics Market, Historic Market Size, 2013-2017
- Table 2 : Global In-Vitro Diagnostics Market, Forecast Market Size, 2017-2021
- Table 3 : Global In-Vitro Diagnostics Market, Split By Region, 2017
- Table 4 : Global In-Vitro Diagnostics Market, Historic and Forecast Growth, By Region, 2013 – 2021
- Table 5 : Global In-Vitro Diagnostics Market, Split By Country, 2017
- Table 6 : Global In-Vitro Diagnostics Market, Historic and Forecast Growth Rate, By Country, 2013-2021
- Table 7 : Global In-Vitro Diagnostics Market, Key Competitor Estimated Market Shares, 2017
- Figure 1 : Global In-Vitro Diagnostics Market, Historic Market Size, 2013-2017
- Figure 2 : Global In-Vitro Diagnostics Market, Forecast Market Size, 2017-2021
- Figure 3 : Global In-Vitro Diagnostics Market, Split By Region, 2017
- Figure 4 : Global In-Vitro Diagnostics Market, Historic and Forecast Growth, By Region, 2013 – 2021
- Figure 5 : Global In-Vitro Diagnostics Market, Split By Country, 2017
- Figure 6 : Global In-Vitro Diagnostics Market, Historic and Forecast Growth Rate, By Country, 2013-2021
- Figure 7 : Global In-Vitro Diagnostics Market, Key Competitor Estimated Market Shares, 2017
The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.